Genmab | GEN - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Genmab

Genmab reported DKK226M in Net Income for its fiscal quarter ending in March of 2023.


Net Income Change
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Almirall SA ALM:SM EUR -23054000 50.39M
Amgen AMGN:US USD 2.84B 1.23B
Artemis Alpha ATS:LN GBP -16638000 10.13M
AstraZeneca AZN:LN USD 1.8B 902M
Bayer BAYN:GR EUR 2.18B 1.57B
BioMarin Pharmaceutical BMRN:US USD 50.85M 51.1M
Bluebird Bio BLUE:US USD 21.24M 10.99M
Demant A/s WDH:DC DKK 1.03B 16M
Exelixis EXEL:US USD 40.03M 70.2M
Fresenius Medical Care FME:GR EUR 86M 52.8M
Galapagos GLPG:NA EUR 23.21M 230.41M
Genmab GEN:DC DKK 226M 358M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
GN Store Nord GN:DC DKK -54000000 317M
Hikma Pharmaceutical HIK:LN USD 15M 158M
Immunogen IMGN:US USD -41014000 17.99M
Insmed INSM:US USD -159764000 359K
Lonza Group LONN:SW CHF 723M 231M
Merck MRK:GR EUR 796M 142M
Novartis NOVN:VX USD 2.29B 827M
Regeneron Pharmaceuticals REGN:US USD 817.8M 379.3M
Roche Holding ROG:VX CHF 3.89B 4.64B
Seattle Genetics SGEN:US USD -174737000 26.57M
UCB UCB:BB EUR 19M 380M